|
AU2015259877B2
(en)
|
2014-05-15 |
2021-02-25 |
National University Of Singapore |
Modified natural killer cells and uses thereof
|
|
US10813952B2
(en)
*
|
2014-11-14 |
2020-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
|
|
CN109844099B
(zh)
*
|
2016-07-25 |
2024-01-02 |
美国政府(由卫生和人类服务部的部长所代表) |
产生经修饰的自然杀伤细胞的方法及使用方法
|
|
US12516292B2
(en)
|
2016-07-25 |
2026-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of producing modified natural killer cells and methods of use
|
|
WO2018104554A1
(en)
*
|
2016-12-09 |
2018-06-14 |
Onkimmune Limited |
Improved nk-based cell therapy
|
|
CN110546265A
(zh)
|
2017-02-09 |
2019-12-06 |
因达普塔治疗公司 |
工程化自然杀伤(nk)细胞及其组合物和方法
|
|
MX2019011570A
(es)
|
2017-03-27 |
2019-11-18 |
Nat Univ Singapore |
Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
|
|
KR102660336B1
(ko)
|
2017-03-27 |
2024-04-26 |
내셔널 유니버시티 오브 싱가포르 |
절단된 nkg2d 키메라 수용체 및 자연 살해 세포 면역요법에서의 그의 용도
|
|
EP3746095A4
(en)
|
2018-02-01 |
2021-04-21 |
Nkmax Co., Ltd. |
Method of producing natural killer cells and composition for treating cancer
|
|
AU2019219454A1
(en)
*
|
2018-02-09 |
2020-08-27 |
National University Of Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
PT3755347T
(pt)
*
|
2018-02-21 |
2025-07-25 |
Univ Texas |
Células de apresentação de antigénio universais e utilizações destas
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|
|
GB201804701D0
(en)
*
|
2018-03-23 |
2018-05-09 |
Gammadelta Therapeutics Ltd |
Lymphocytes expressing heterologous targeting constructs
|
|
CN112055717B
(zh)
|
2018-04-02 |
2024-04-26 |
新加坡国立大学 |
用在免疫细胞中表达的膜结合抗细胞因子非信号传导粘合剂中和人细胞因子
|
|
IL278723B2
(en)
*
|
2018-05-16 |
2024-07-01 |
Res Inst Nationwide Childrens Hospital |
Generation of knock-out primary and expanded human nk cells using cas9 ribonucleoproteins
|
|
AU2019275067A1
(en)
*
|
2018-05-23 |
2020-12-17 |
Manysmart Therapeutics, Inc. |
Bispecific T cell engager and uses thereof
|
|
JP2021525066A
(ja)
*
|
2018-05-30 |
2021-09-24 |
グリコステム セラピューティクス ベスローテン フェンノートシャップ |
Ｃａｒ ｎｋ細胞
|
|
US20210230542A1
(en)
*
|
2018-06-06 |
2021-07-29 |
Stemcell Technologies Canada Inc. |
Kits, compositions and methods for cell enrichment
|
|
WO2020028656A1
(en)
|
2018-08-01 |
2020-02-06 |
Nantkwest, Inc. |
A quadricistronic system comprising a homing receptor or a cytokine, and chimeric antigen receptor for genetic modification of immunotherapies
|
|
CA3110922A1
(en)
*
|
2018-08-28 |
2020-03-05 |
Immunotech Biopharm Co., Ltd. |
Improved therapeutic t cell
|
|
WO2020042648A1
(zh)
*
|
2018-08-28 |
2020-03-05 |
法罗斯疫苗株式会社 |
改进的慢病毒载体
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
CN110511912B
(zh)
*
|
2018-08-30 |
2024-03-22 |
浙江煦顼技术有限公司 |
免疫细胞的功能调节
|
|
WO2020077091A1
(en)
*
|
2018-10-10 |
2020-04-16 |
Wisconsin Alumni Research Foundation |
Kir 7.1 gene therapy vectors and methods of using the same
|
|
CN109402053A
(zh)
*
|
2018-10-17 |
2019-03-01 |
广州元帅生物科技有限公司 |
一种外周血来源单个核细胞的分离及诱导培养方法
|
|
US12410402B2
(en)
*
|
2018-11-21 |
2025-09-09 |
Indapta Therapeutics, Inc. |
Methods for expansion of natural killer (NK) cell subset and related compositions and methods
|
|
US12590148B2
(en)
|
2018-11-26 |
2026-03-31 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
EP3927730A4
(en)
*
|
2019-02-20 |
2022-12-21 |
Rutgers, The State University of New Jersey |
EXPANSION OF NATURAL KILLER CELLS AND CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS
|
|
AU2020232691B2
(en)
|
2019-03-05 |
2023-06-29 |
Nkarta, Inc. |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
WO2020190771A1
(en)
|
2019-03-15 |
2020-09-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric adaptor and kinase signaling proteins and their use in immunotherapy
|
|
KR20200110576A
(ko)
*
|
2019-03-15 |
2020-09-24 |
재단법인대구경북과학기술원 |
사이토카인 기반 면역세포 및 그의 면역 치료 용도
|
|
EP3712257A1
(en)
*
|
2019-03-21 |
2020-09-23 |
ONK Therapeutics Limited |
Modified natural killer cells with increased resistance to cell death
|
|
AU2020242305A1
(en)
*
|
2019-03-21 |
2021-09-30 |
Onk Therapeutics Limited |
Modified immune effector cells with increased resistance to cell death
|
|
CN110079529A
(zh)
*
|
2019-04-28 |
2019-08-02 |
成都美杰赛尔生物科技有限公司 |
用于靶向敲除人NKG2A/KLRC1基因的sgRNA、表达载体、试剂盒及其用途
|
|
CN110106202A
(zh)
*
|
2019-05-07 |
2019-08-09 |
杭州师范大学 |
抗肿瘤nk细胞的制备方法及其细胞与应用
|
|
MX2021015448A
(es)
*
|
2019-06-14 |
2022-06-08 |
G Tech Bio Llc |
Células linfocíticas activadas y métodos para usarlas para tratar cáncer y afecciones infecciosas.
|
|
CN110205293A
(zh)
*
|
2019-06-25 |
2019-09-06 |
中冠赛尔生物科技(北京)有限公司 |
一种加强型高效治疗肺癌的nk免疫细胞的制备方法及应用
|
|
US20210077527A1
(en)
*
|
2019-09-13 |
2021-03-18 |
The Research Institute At Nationwide Children's Hospital |
Universal donor selection method to identify nk-cell-donors
|
|
WO2021051088A1
(en)
*
|
2019-09-13 |
2021-03-18 |
Ohio State Innovation Foundation |
Nk cell immunotherapy compositions, methods of making and methods of using same
|
|
US11230699B2
(en)
|
2020-01-28 |
2022-01-25 |
Immunitybio, Inc. |
Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors
|
|
KR20220165254A
(ko)
|
2020-03-26 |
2022-12-14 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
Cd28h 도메인을 함유하는 키메라 항원 수용체 및 그 사용 방법
|
|
CN113528452B
(zh)
*
|
2020-07-06 |
2023-06-06 |
上海鑫湾生物科技有限公司 |
共表达IL-21和hrCD16嵌合受体的免疫细胞及其应用
|
|
CN116568805A
(zh)
*
|
2020-09-02 |
2023-08-08 |
恩卡尔塔公司 |
工程化自然杀伤细胞的增强扩增和细胞毒性及其用途
|
|
EP3964265A1
(en)
*
|
2020-09-07 |
2022-03-09 |
Fundacion Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz |
Mesenchymal stem cells co-expressing cxcr4 and il-10 and uses thereof
|
|
CN112029721A
(zh)
*
|
2020-09-09 |
2020-12-04 |
广东昭泰体内生物医药科技有限公司 |
一种活性增强型nk细胞的制备方法
|
|
KR102581230B1
(ko)
*
|
2020-10-16 |
2023-09-21 |
의료법인 성광의료재단 |
항암 관련 유전자 발현이 조절된 자연살해세포 및 이의 용도
|
|
US20240009236A1
(en)
|
2020-11-04 |
2024-01-11 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Modified nk cells with reduced ccr5 expression and methods of their use
|
|
WO2022226130A1
(en)
*
|
2021-04-21 |
2022-10-27 |
Indapta Therapeutics, Inc. |
Methods of treatment and dosing of natural killer cell compositions
|
|
CN115505572B
(zh)
*
|
2021-06-22 |
2025-11-14 |
康立泰生物医药(青岛)有限公司 |
一种增强型抗肿瘤nk细胞及其制备方法和应用
|
|
EP4395838A1
(en)
*
|
2021-08-30 |
2024-07-10 |
CarryGenes Bioengineering, LLC |
tCD34 AND OTHER MARKERS FOR IDENTIFICATION AND SORTING OF CELLS AND FOR USE ASIN VIVO TRACKING ASSISTANT
|
|
WO2023044304A1
(en)
|
2021-09-15 |
2023-03-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric adaptor and kinase signaling proteins and their use in immunotherapy
|
|
CN114306606B
(zh)
*
|
2021-11-29 |
2023-05-26 |
江苏省人民医院（南京医科大学第一附属医院） |
cGAS抑制剂在制备治疗T细胞淋巴瘤的药物中的应用
|
|
CN114381434A
(zh)
*
|
2022-01-17 |
2022-04-22 |
华东师范大学 |
一种趋化型car-nk细胞及其制备方法和应用
|
|
CN114807237A
(zh)
*
|
2022-05-12 |
2022-07-29 |
广东普罗凯融生物医药科技有限公司 |
一种过表达CD16a的NK细胞的制备方法及其应用
|
|
CN115074325A
(zh)
*
|
2022-07-07 |
2022-09-20 |
广州希灵生物科技有限公司 |
Herceptin联合4-1BBL体外扩增NK方法
|
|
CN115466726B
(zh)
*
|
2022-09-05 |
2023-09-19 |
北京景达生物科技有限公司 |
一种nk细胞的高效基因转导方案
|
|
CN116178566A
(zh)
*
|
2022-09-30 |
2023-05-30 |
深圳博雅感知药业有限公司 |
靶向cd33的嵌合抗原受体和制备b16-cd33 car-nk细胞的方法
|
|
CN115975922B
(zh)
*
|
2022-12-15 |
2024-06-28 |
杭州师范大学 |
Bx795在制备nk-92细胞激活剂上的应用
|
|
WO2024131685A1
(zh)
*
|
2022-12-19 |
2024-06-27 |
苏州沙砾生物科技有限公司 |
一种细胞培养方法及其用途
|
|
AU2024311300A1
(en)
|
2023-06-20 |
2026-01-15 |
Zelluna Immunotherapy As |
Methods of enhancing or modifying nk cells
|
|
WO2025232819A1
(en)
*
|
2024-05-08 |
2025-11-13 |
Qihan Hong Kong Limited |
Immunotherapies using engineered cells for enhanced bone marrow homing
|
|
EP4692325A1
(en)
*
|
2024-08-07 |
2026-02-11 |
Miltenyi Biotec B.V. & Co. KG |
Method for generation of a composition comprising natural killer cells
|